Skip to content
Psychedelics Today cover art

All Episodes

Psychedelics Today — 779 episodes · page 5 of 8

#
Title
401

PT290 – Kylea Taylor, M.S., LMFT – Vital Psychedelic Conversations

402

PT289 – Payton Nyquvest – Shifting the Mindset on Pain, Psychedelics, and Accessibility

403

PT283 – Greg McKee – Psychedelics for Nociplastic Pain

404

PT281 – Oliver Grundmann, Ph.D. – A Thorough Exploration of Kratom

405

PT288 – Annie & Michael Mithoefer – Vital Psychedelic Conversations

406

PT287 – Josh Hardman – Psychedelic Stocks, Data Privacy, and Drug Development

407

PT286 – Joe Tafur, MD – Vital Psychedelic Conversations

408

PT285 – Andrew Penn, NP – The Need for Nurses in Psychedelics, The Placebo Effect, and Appreciating the Subtle

409

PT284 – Jonathan Sabbagh – Ketamine-Assisted Psychotherapy and Collaborative Care

410

PT282 – Rabbi Zac Kamenetz & The Rev. Hunt Priest – Judaism, Christianity, and Embracing Psychedelics

411

PT280 – Danny Peterson ​​– Psychedelics, Religion, and Freedom

412

PT279 – Joe Zap & Kevin W – Cannabis Acceptance, Conspiratorial Thinking, and Psychedelic Podcasting

413

PTSF90 – Colorado's Natural Medicine Healing Act and Guidelines for Emergency Ketamine Administration

414

PT278 – Ayize Jama-Everett, Courtney Watson, Leticia Brown, and Kufikiri Imara – A Table of Our Own

415

PTSF89 – A Macro Dive Into Microdosing

416

PT277 – Ryan Zurrer – Venture Capital, Reciprocity, and the Regenerative Financing Vine

417

PTSF88 – Dr. Ben Sessa of Awakn Life Sciences + Josh Bartch of Mydecine Innovations Group

418

PT276 – Micah Haskell-Hoehl – Healing, Equity, and Federal Policy

419

PTSF87 – Ketamine, Addiction, and Mysticism + Kelsey Ramsden of MINDCURE

420

PT275 – James Fadiman, Ph.D. – Transpersonal Psychology, Microdosing, and Your Symphony of Selves

421

PTSF86 – Ayahuasca, Chronic Pain, and Legal Psilocybin, with Payton Nyquvest of Numinus

422

PT274 – Juan Pablo Cappello – Nue Life: Using Digital Phenotyping to Personalize Healthcare

423

PTSF85 – Ahmad Doroudian, Ph.D. of BetterLife Pharma and Dr. Abid Nazeer of Wesana Health

424

PT273 – Erica Rex – Clinical Trials and Spontaneous Mystical Experiences

425

PT272 – Veterans Day 2021

426

PTSF84 – A Brief Check-in From Wonderland

427

PT271 – Jeremy Narby, Ph.D. – Anthropology, Ayahuasca, and Plant Teachers

428

PT270 – Dr. Rachel Yehuda – Research Trials and The Future of Psychedelic Neuroscience

429

PT269 – Adam Strauss – Comedy, OCD, and The Mushroom Cure

430

PTSF83 – Abuse in Psychedelics: Complicity and Groupthink

431

PT268 – Hamilton Morris – PCP, 5-MeO-DMT, and The Synthesis of New Psychedelics

432

PTSF82 – Wonderland Miami, with Patrick Moher of Microdose

433

PT267 – Rebecca Kronman, LCSW – Pregnancy, Parenthood, and Psychedelics

434

PTSF81 – Somatics, Reframing Trauma, and the 7 Lens Approach, with Liam Farquhar

435

PT266 – Jerry B. Brown, Ph.D. – Psychedelics: Past, Present, and Future

436

PTSF80 – Decriminalization in Seattle, San Pedro, and The Dark Web

437

PT265 – Jessica Cadoch, MA – Cooperation, Drug Exceptionalism, and 12-step Programs

438

PTSF79 - Psychedelic Facilitator Abuse and Space Holding Ethics with Dr. Ido Cohen

439

PT264 – Gibrán Rivera – Group Process, Self-sovereignty, and Rethinking Masculinity

440

PTSF78 – Navigating the Vast Psychedelic Space: Where Do You Fit In?

441

PT263 – Michelle Janikian – 920: The Magic Mushroom Holiday

442

PTSF77 – Progress and Context, with Jesse Gould of Heroic Hearts Project

443

PT262 – Carlene MacMillan, M.D. – Set, Setting, and Systems: Adding Insurance to the Conversation

444

PTSF76 – Spiritual Emergence and Healing

445

PT261 – Dr. Tiago Reis Marques – Ketamine, New Drugs, and the Repurposing of Current Drugs

446

PTSF75 – Possession Limits, Religion, and Scalability

447

PT260 – Benjamin Mudge – Ayahuasca and Bipolar: Pathways to a Protocol

448

PTSF74 – A Response: Decriminalize Nature, SB-519, and MAPS

449

PT259 – Dr. Devon Christie and Will Siu, MD, DPhil – The Mind-Body Connection, MDMA, and Chronic Pain

450

PTSF73 – Origin Stories, Complexity, and Transpersonal Psychology

451

PT258 – Manesh Girn – Psychedelics and the Brain: Neuroplasticity and Creativity

452

PTSF72 – Breaking Down SB-519, with MAPS' Ismail L. Ali

453

PT257 – Robin Divine – Black People Trip

454

PTSF71 – Sexual Ethics in Psychedelics and Mistrust of Big Pharma

455

PT256 – Matthew D. Segall, Ph.D. – Consciousness, Capitalism, and Philosophy

456

PTSF70 – Depth Psychology, The Reach of the DEA, and Progress in the Northeast

457

PT255 – Jasmine Virdi – Conservation, Covid, and Neurodivergence

458

PTSF69 – Well-being and Working With Weirdness

459

PT254 – Daniel Moler – San Pedro, Comic Books, and Finding Your Flow

460

PTSF68 – Neuroplasticity, Michael Pollan, and DMT, with Manesh Girn

461

PT253 – Sean Hinton Ph.D. – Culture, Research Limitations, and Non-Medical Paths Forward

462

PTSF67 – Psilocybin, Power, and Patents

463

PT252 – Joel Lambert – Ibogaine, 5-MeO-DMT, and The Warrior Tradition

464

PTSF66 – Philosophical Critiques, Legalization Updates, and Inclusive Research

465

PT251 – Kristina & Jonas of the Psychedelic Literacy Fund – Celebrating Stan Grof

466

PT250 – Matt – New Frameworks For Schizophrenia, Dissociation, and Suicidal Ideation

467

PTSF65 - Navigating Psychedelics for Clinicians and Therapists, and Nitrous Oxide for Depression

468

PT249 – Hadas Alterman, Serena Wu, and Adriana Kertzer of Plant Medicine Law Group

469

PTSF64 - The First Woman to Take Acid, The Drug Policy Reform Act, and Indigenous Language Extinction

470

PT248 – Pierre Bouchard – Somatic Therapy, Trauma, and the Nervous System

471

PTSF63 - The Media and Legalization, Joints for Jabs, and 40,000 Ecstasy Pills

472

PT247 – Julian Vayne – Magic, Prohibition, and New Models for Legality

473

PTSF62 - Senate Bill 519, Ketamine, and Psilocybin-producing Cicadas

474

PT246 - Amber and Marcus Capone of VETS - Foundational Healing and the Brain

475

PTSF61 – Archetypal Astrology and the Inner Healer, with Renn Butler

476

PT245 – Robin Carhart-Harris – Psychedelics, Entropy, and Plasticity

477

PTSF60 – Representation and Access, with Elan Hagens and Rebecca Martinez of Fruiting Bodies Collective

478

PT244 – Mark Haberstroh – Mushrooms, Retreat Centers, and Safety

479

PTSF59 – Psychedelics and Bipolar, with Benjamin Mudge

480

PT243 – Dr. Fernando Espi Forcen and Dr. Franklin King of MGH's Center for the Neuroscience of Psychedelics

481

PTSF58 - Liberty, The Power of Therapy, and Mushrooms in Maine

482

PT242 - Gary Laderman - Religion: Sex, Death, and Drugs

483

PTSF57 - New Compounds, Psychedelic Business, and Neurogenesis

484

PTSF57 - New Compounds, Psychedelic Business, and Neurogenesis

485

PT241 - Tyler Chandler and Nick Meyers of "Dosed": Iboga and The Opioid Crisis

486

PTSF56- Data vs. Spin, with Tim Cools of Psychedelic Experience

487

PT240 - Ralph Blumenthal - Alien Abductions and The Believer

488

PTSF55 - Creativity, Group Ceremony, and Astral Projection

489

PT239 - Richie Ogulnick - Ibogaine, Unicity, and Beneficence

490

PTSF54 - Theft, Patents, and Ethical Psychedelic Companies

491

PT238 - Kile Ortigo - Integration and Existential Exploration

492

PTSF53 - Psychedelics and Creativity, with Laura Dawn

493

PT237 - Dena Justice - Finding the Frequency of Safety

494

PTSF52 - Start Low, Go Slow

495

PT236 - Dr. Carl Hart - Drugs: Honesty, Responsibility, and Logic

496

PTSF51 - Miracle Cures, Money, and Standing on the Shoulders of Giants

497

PT235 - The Entheo Society of Washington - Dismantling Power Systems Through Decriminalization

498

PTSF50 - Microdosing and the Placebo Effect, with Balázs Szigeti and David Erritzoe

499

PT234 - Christopher Solomon - Salvia as a Therapist

500

PTSF49 - MDMA For Alcoholism, The Placebo Effect, and Ceremonial Magicians